A man whose scapula was spared a drug-associated rash

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 6, 2005, Pages 745-

  Sanz, Álvaro ^a   Del Valle, María Luisa ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEFITINIB; GEMCITABINE; NAVELBINE; OPIATE;

ACNE; ADULT; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; HUMAN; LUNG CARCINOMA; LUNG METASTASIS; MALE; MEDIASTINUM METASTASIS; PALLIATIVE THERAPY; RASH; SCAPULA; SHORT SURVEY; SHOULDER PAIN; TRUNK;

EID: 15244359407     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1040795     Document Type: Short Survey

References (2)

1. Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer. J Clin Oncol 2003;21:2237-46.
2. Lee MW, Seo CW, Kim SW, Yang HJ, Lee HW, Choi JH, et al. Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor. Acta Derm Venereol 2004;84:23-6.